Replies to post #56629 on Applied DNA Sciences Inc (APDN)

[mcsharkey]

Thank_You_ROCKET, keeping_our_little_light_shining:). AppreciateYa! Got_some_PR__level_news on_a_LineaRX_collaboration we_got_going_on TYME Presents Business Update and Announces Second Quarter Fiscal 2020 Conference Call and Preliminary Operational Results

We got our first alert on our "collaboration" with TYME just back on the 1st of October @THIS LINK. I like this very promising NYC cancer research group we're collaborated with through LineaRX, as much as I used to like Theracann. And, they're still on the table. Too many issues, and just blowing smoke to discuss pot. Need to pull for our business on LineaRX because:

① They already are listed (TYME) on the NASDAQ.

② They have real cash. As of September 30, 2019, the end of its second fiscal quarter, the Company had approximately $15.3 million in cash and cash equivalents compared to $19.5 million as of June 30, 2019. TYME’s operational cash burn rate for the second quarter of fiscal year 2020 was $4.2 million compared to $4.7 million for the second quarter of fiscal year 2019.

And on Thursday, reported results of this recently completed Phase II trial using SM-88 to treat recurrent prostate cancer at the Congress of the European Society of Medical Oncology (ESMO), one of the preeminent meetings for highlighting new cancer therapies and diagnostics.

All I got for a bit.

Hoping everyone is voting. And voting YES on Proposal 2.

PROPOSAL 2
APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO SOLICIT ADDITIONAL PROXIES

In the event that the number of shares of our common stock present in person or represented by proxy at the Special Meeting and voting “FOR” the adoption of the Reverse Stock Split is insufficient to adopt the Reverse Stock Split, we may move to adjourn the Special Meeting in order to enable the Board to solicit additional proxies in favor of the adoption of the Reverse Stock Split. In that event, we will ask stockholders to vote only upon this Proposal 2 and not on Proposal 1. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

If a quorum is present, Proposal 2, approval of the proposal to adjourn the Special Meeting to a later date, requires the affirmative vote of the majority of the votes cast on the proposal. Abstentions and broker non-votes will not be considered votes cast on Proposal 2 and will therefore not have any effect with respect to Proposal 2.

The Board Recommends a Vote FOR the Adjournment of the Special Meeting to Solicit Additional Proxies if there Are Insufficient Proxies at the Special Meeting to Approve the Reverse Stock Split. Proxies that Are Returned Will Be so Voted Unless Otherwise Instructed.

GLTUA